Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
aTyr Pharma, Inc. - Common Stock
(NQ:
ATYR
)
1.000
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about aTyr Pharma, Inc. - Common Stock
< Previous
1
2
3
Next >
Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
October 16, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
October 16, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
Faruqi & Faruqi Reminds ATyr Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 9, 2025 - ATYR
October 16, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Why Is aTyr Stock Falling Today?
September 15, 2025
Via
Stocktwits
Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
October 15, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
aTyr Pharma, Inc.’s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
October 15, 2025
From
Hagens Berman
Via
Business Wire
ATYR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against aTyr Pharma, Inc. and Encourages Investors to Contact the Firm
October 14, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
October 12, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
October 12, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
ATYR Investor Notice: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against aTyr Pharma, Inc.
October 10, 2025
From
Robbins LLP
Via
GlobeNewswire
aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR
October 10, 2025
From
DJS Law Group
Via
Business Wire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
October 10, 2025
From
The Schall Law Firm
Via
Business Wire
Rosen Law Firm Urges aTyr Pharma, Inc. (NASDAQ: ATYR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
October 10, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
October 10, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR
September 24, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs
September 20, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via
Benzinga
Top 3 Health Care Stocks That May Explode In September
September 19, 2025
Via
Benzinga
Goldman Sachs To Rally around 9%? Here Are 10 Top Analyst Forecasts For Tuesday
September 16, 2025
Via
Benzinga
Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September
September 15, 2025
Via
Benzinga
Which stocks are most active on Monday?
September 15, 2025
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
September 15, 2025
Via
Benzinga
aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR
September 15, 2025
From
DJS Law Group
Via
Business Wire
ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results
September 15, 2025
ATyr Pharma's stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung function and steroid withdrawal rates.
Via
Benzinga
Nasdaq Gains Over 100 Points; Tesla Shares Spike Higher
September 15, 2025
Via
Benzinga
New Mountain Finance, Texas Instruments, Analog Devices And Other Big Stocks Moving Lower In Monday's Pre-Market Session
September 15, 2025
Via
Benzinga
Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarket
September 15, 2025
Via
Benzinga
Why Is Atyr Pharma Stock Slipping Premarket?
September 15, 2025
Investors braced for imminent Phase 3 EFZO-FIT trial results of efzofitimod, with analysts calling it a key inflection point.
Via
Stocktwits
1 Small-Cap Biotech Stock Poised for a Breakout
September 11, 2025
The next couple of weeks could reveal a great deal about this stock's prospects.
Via
The Motley Fool
Nvidia To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Friday
August 22, 2025
Via
Benzinga
Alerus Financial Posts Better-Than-Expected Earnings, Joins Celcuity, SES AI, Abercrombie & Fitch And Other Big Stocks Moving Higher On Monday
July 28, 2025
Via
Benzinga
Topics
Artificial Intelligence
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.